Metropolis Healthcare
Latest, :
Latest moves
Our read of each move first, where we have one; what the report said is marked Reported.
- Reported: Metropolis’s 70–75 new smaller-town labs and reach across roughly 750 towns show that localized network expansion is scaling into a demand and revenue driver.Reported: Metropolis Healthcare has added 70–75 labs in smaller towns over three years and now serves about 750 towns. Metropolis deepens tier-II and III diagnostics network as smaller towns drive growth.Watch:
- Reported: Metropolis must deliver FY27 growth through 9–10% volume gains and a premium-test mix shift, making lab utilization, wellness conversion and specialty-test execution more important than pricing.Reported: Metropolis rules out price hikes, guides 14–15% FY27 revenue growth. Mumbai-based diagnostics chain Metropolis Healthcare expects growth to come from 9–10% higher volumes and a richer premium wellness and specialty-test mix, not price increases.Watch:
Background
From 6 stories, the newest dated 27 Sept 2026. Summary written 3 Oct 2026.
Metropolis Healthcare is a diagnostics chain operating in India.
Show 3 more paragraphs and 6 sources
Business Standard reported in September 2026 that it has around 209-210 laboratories and more than 5,000 touchpoints across 750+ towns.[1] source: Business Standard About 27-28% of its business comes from tier-III towns and beyond, Mint reported in August 2026.[2] source: Mint Its businesses include Core Diagnostics and TruHealth.[3] source: Business Standard
For Q1 FY27, reported in August 2026, Metropolis posted consolidated net profit of ₹57 crore, up 25.8% year-on-year from ₹45 crore, and revenue from operations of ₹450 crore, up 16.6% from ₹386 crore.[4] source: CNBC-TV18 Its FY26 revenue was Rs 1,646 crore.[1] source: Business Standard In September 2026, Crisil upgraded its outlook to positive and kept the AA- rating.[3] source: Business Standard The company guided to 14-15% FY27 revenue growth with no price hikes budgeted this year.[5] source: CNBC-TV18 In September 2026 it set a target of more than Rs 2,500 crore revenue and 27-28% EBITDA margin within three years, with 1,000 company-owned centres, up from around 750.[1] source: Business Standard It also plans to use AI and automation to improve productivity and workflows.[6] source: Business Today
Dr. Lal PathLabs is named alongside Metropolis in Mint's August 2026 report on tier-II and III diagnostics networks.[2] source: Mint
Sources
Questions about Metropolis Healthcare
How many Metropolis Healthcare stores are there?
Metropolis Healthcare had more than 5,000 touchpoints across 750+ towns and around 750 company-owned centres, Business Standard reported in September 2026.[1] source: Business Standard
How fast is Metropolis Healthcare growing in India?
Metropolis Healthcare reported Q1 FY27 revenue from operations of ₹450 crore, up 16.6% from ₹386 crore, and consolidated net profit of ₹57 crore, up 25.8% year-on-year, in August 2026.[4] source: CNBC-TV18
What is Metropolis Healthcare's current strategy in India?
In September 2026 Metropolis Healthcare set a target of 1,000 company-owned centres and more than Rs 2,500 crore revenue within three years.[1] source: Business Standard It also plans to use AI and automation to improve productivity and workflows.[6] source: Business Today In August 2026 it said no price hikes were budgeted for FY27.[5] source: CNBC-TV18
Stories that mention Metropolis Healthcare
1 story
Metropolis Healthcare is named in these stories but is not their subject.